Tavneos, a rare autoimmune drug linked to over 20 deaths in Japan, is being recalled across Europe—including Ireland and France—after regulators found its risks outweighed its benefits, though causation isn’t confirmed. Amgen’s medication, used for severe vascular inflammation, has been pulled from shelves as specialists shift patients to alternatives, with health authorities urging current users not to stop treatment without medical advice. The UK is still reviewing the drug’s safety.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
